ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

258 hedge funds and large institutions have $5.24B invested in Alnylam Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 82 increasing their positions, 83 reducing their positions, and 20 closing their positions.

Holders
258
Holders Change
+10
Holders Change %
+4.03%
% of All Funds
6.89%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.24%
New
33
Increased
82
Reduced
83
Closed
20
Calls
$65.6M
Puts
$37.2M
Net Calls
+$28.4M
Net Calls Change
-$6.66M

Top Buyers

1
Dodge & Cox
1
Dodge & Cox
California
$358M
2
BM
2
Bridger Management
New York
$66.6M
3
PAMU
3
Pictet Asset Management (UK)
United Kingdom
$20.6M
4
Goldman Sachs
4
Goldman Sachs
New York
$63.9M
5
PCM
5
Peregrine Capital Management
Minnesota
$12.5M

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
Wells Fargo
2
Wells Fargo
California
$31.7M
3
Jennison Associates
3
Jennison Associates
New York
$53M
4
UBS AM
4
UBS AM
Illinois
$103M
5
ZBI
5
Ziff Brothers Investments
New York
$14.9M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$872M 12,858,695 +24,615 +0.2%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$813M 11,997,479 +25,696 +0.2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$367M 5,417,949 +32,440 +0.6%
Dodge & Cox
4
Dodge & Cox
California
$358M 5,276,068 +2,759,399 +110%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$273M 4,025,408 +29,266 +0.7%
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$228M 3,368,325 -21,927 -0.6%
State Street
7
State Street
Massachusetts
$158M 2,333,176 +137,672 +6%
BFA
8
BlackRock Fund Advisors
California
$131M 1,927,337 +56,455 +3%
BIT
9
BlackRock Institutional Trust
California
$129M 1,902,343 -23,987 -1%
UBS AM
10
UBS AM
Illinois
$103M 1,518,762 -144,120 -9%
GGHC
11
Gilder Gagnon Howe & Co
New York
$92.3M 1,361,656 -32,291 -2%
BRC
12
Blue Ridge Capital
New York
$89.5M 1,320,000 – –
SPC
13
Slate Path Capital
New York
$83M 1,225,000 +90,000 +8%
BB
14
BB Biotech
Switzerland
$80.7M 1,191,338 – –
BM
15
Bridger Management
New York
$66.6M 983,040 +296,031 +43%
RI
16
RTW Investments
New York
$64.3M 948,286 +115,737 +14%
Goldman Sachs
17
Goldman Sachs
New York
$63.9M 942,859 +249,691 +36%
Morgan Stanley
18
Morgan Stanley
New York
$57M 840,412 -34,692 -4%
Jennison Associates
19
Jennison Associates
New York
$53M 781,656 -193,769 -20%
Franklin Resources
20
Franklin Resources
California
$48.4M 714,000 +122,000 +21%
1WCM
21
12 West Capital Management
New York
$47.4M 700,000 – –
AG
22
Artal Group
Luxembourg
$40.7M 600,000 -110,000 -15%
Capital World Investors
23
Capital World Investors
California
$38.9M 573,700 – –
Norges Bank
24
Norges Bank
Norway
$35.5M 547,769 +87,008 +19%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$35.2M 519,905 +20,289 +4%
1
2 3 4 5